摘要
2022年中成药治疗糖尿病肾脏病临床应用专家共识正式发布。该共识基于解决临床关键问题,推荐了16种中成药用于糖尿病肾脏病的治疗,涉及6类中医证型,对每种中成药的治疗机制、疗效指标、用法用量、注意事项和适用人群等进行了推荐。现主要介绍该共识的制订背景和方法,并对该专家共识的相关内容进行解读。
In 2022,the expert consensus on clinical application of Chinese patentmedicine for diabetes kidney disease will be officially released.Based on solving key clinical problems,the consensus recommended 16 kinds of Chinese patent medicines for the treatment of diabetes kidney disease,involving six types of TCM syndromes,and recommended the treatment mechanism,efficacy indicators,usage and dosage,precautions and applicable population of each kind of Chinese patent medicine.This paper mainly introduces the background and method of the consensus,and interprets the relevant contents of the expert consensus.
作者
柳小远
于小勇
Liu Xiaoyuan;YU Xiaoyong(Shaanxi Provincial Hospital of Traditional Chinese Medicine,Xi'an 710000,China)
出处
《现代中医药》
CAS
2023年第1期24-30,共7页
Modern Chinese Medicine
基金
国家自然科学基金项目(82174366)。
关键词
中成药
糖尿病肾病
专家共识
解读
Chinese patent medicine
Diabetes kidney disease
Expert consensus
Interpretation
